Statistics

Total Visits

Views
Progression-Free Survival at 24 Months (PFS24) and Complete Response at 30 Months (CR30) from Autologous Stem Cell Transplantation (ASCT) Should be Used As Surrogates for OS in Follicular Lymphoma (FL) Patients39

Select a period of time:

Number of views in the range

Views
Progression-Free Survival at 24 Months (PFS24) and Complete Response at 30 Months (CR30) from Autologous Stem Cell Transplantation (ASCT) Should be Used As Surrogates for OS in Follicular Lymphoma (FL) Patients9

Views

Views
June 20250
July 20257
August 20250
September 20250
October 20250
November 20252
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil4
United States2
Argentina2
Turkey1
 

Top cities views

Views
Cleveland1
Decatur1
Goiânia1
Istanbul1
Joinville1
João Lisboa1
Morón1
Quilmes1
Sorocaba1